It's called ibrutinib, and it's a potential breakthrough in treating chronic lymphocytic leukemia (CLL) that could leave patients with fewer side effects than chemotherapy.
via CNN.com - Top Stories http://edition.cnn.com/2013/06/20/health/time-leukemia-drug/index.html?eref=edition
via CNN.com - Top Stories http://edition.cnn.com/2013/06/20/health/time-leukemia-drug/index.html?eref=edition
No comments:
Post a Comment